Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design
暂无分享,去创建一个
David Haussler | Jacob Pfeil | Olena Morozova Vaske | Casey S. Greene | Sharon J. Diskin | John M. Maris | Huiyuan Zhang | Sibo Zhao | Jay Bowen | Kathryn Evans | Karthik Kalletla | Joy Jayaseelan | David A. Wheeler | Gregory P. Way | Khushbu Patel | Komal S. Rathi | Christopher Morton | Jo Lynne Rokita | E. Anders Kolb | Richard Gorlick | Siyuan Zheng | Yidong Chen | D. Haussler | D. Wheeler | P. Raman | J. Bowen | J. Gastier-Foster | H. Doddapaneni | J. Maris | C. Greene | P. Houghton | J. Jayaseelan | S. Diskin | Jacob Pfeil | Siyuan Zheng | Yidong Chen | Y. Sanchez | C. Morton | R. Lock | Y. Mossé | Malcolm A. Smith | Z. Momin | C. Mayoh | Xiao-Nan Li | M. Haber | K. Rathi | Lin Qi | C. Reynolds | R. Gorlick | Alvin Farrel | Z. Vaksman | G. Marshall | Kateryna Krytska | Pichai Raman | HarshaVardhan Doddapaneni | Zalman Vaksman | H. Lindsay | Lori S. Hart | S. Coppens | Michelle Haber | F. Braun | Yael P. Mosse | Wendong Zhang | Dias Kurmashev | R. Kurmasheva | Sibo Zhao | E. Kolb | Alvin Farrel | Peter J. Houghton | Xiao-Nan Li | C. Patrick Reynolds | K. Evans | Zeineen Momin | Vanessa Tyrrell | Richard B. Lock | Glenn M. Marshall | Chelsea Mayoh | Julie M. Gastier-Foster | Kristen M. Leraas | Julia W. Böhm | Esther R Berko | Patricia Baxter | Maria F. Cardenas | Kristen A. Upton | Katherine L. Cross | Laura E. Egolf | Nathan M. Kendsersky | Krutika S. Gaonkar | Apexa Modi | Esther R. Berko | Gonzalo Lopez | Jonas Nance | Kristyn McCoy | Hannah McCalmont | Katerina Bendak | Frank K. Braun | Lin Qi | Yunchen Du | Holly B. Lindsay | Jack Shu | Dias Kurmashev | Anthony C. Bryan | Sara E. Coppens | Gregory I. Sacks | Gregory J. Gatto | Yolanda Sanchez | Raushan T. Kurmasheva | A. C. Bryan | O. Vaske | P. Baxter | V. Tyrrell | H. Mccalmont | Apexa Modi | N. Kendsersky | Khushbu Patel | Gonzalo López | Jonas Nance | Kristyn Mccoy | K. Bendak | Karthik Kalletla | Yu-Yun Du | J. Shu | Wendong Zhang | K. Krytska | K. Leraas | G. Gatto | Huiyuan Zhang
[1] Gennady Korotkevich,et al. Fast gene set enrichment analysis , 2019, bioRxiv.
[2] Allison P. Heath,et al. Pediatric High Grade Glioma Resources From the Children’s Brain Tumor Tissue Consortium (CBTTC) and Pediatric Brain Tumor Atlas (PBTA) , 2019, bioRxiv.
[3] Daniel Martinez,et al. An antibody-drug conjugate directed to the ALK receptor demonstrates efficacy in preclinical models of neuroblastoma , 2019, Science Translational Medicine.
[4] David T. W. Jones,et al. A biobank of patient-derived pediatric brain tumor models , 2018, Nature Medicine.
[5] Yassen Assenov,et al. Maftools: efficient and comprehensive analysis of somatic variants in cancer , 2018, Genome research.
[6] Christopher T. Saunders,et al. Strelka2: fast and accurate calling of germline and somatic variants , 2018, Nature Methods.
[7] J. Maris,et al. Abstract LB-136: Pediatric Preclinical Testing Consortium evaluation of a DLL3-targeted antibody drug conjugate rovalpituzumab tesirine, in neuroblastoma , 2018, Clinical Research (Excluding Clinical Trials).
[8] E. Lecona,et al. Targeting ATR in cancer , 2018, Nature Reviews Cancer.
[9] Michael C. Heinold,et al. Author Correction: The landscape of genomic alterations across childhood cancers , 2018, Nature.
[10] Peter J. Park,et al. Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing , 2018, bioRxiv.
[11] Michael T. Zimmermann,et al. Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas , 2018, Cell reports.
[12] Gregory P. Way,et al. Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas , 2018, Cell reports.
[13] Michael C. Heinold,et al. The landscape of genomic alterations across childhood cancers , 2018, Nature.
[14] Xin Zhou,et al. Pan-cancer genome and transcriptome analyses of 1,699 pediatric leukemias and solid tumors , 2018, Nature.
[15] Hua Sun,et al. TissGDB: tissue-specific gene database in cancer , 2017, Nucleic Acids Res..
[16] B. Teicher,et al. Abstract LB-B16: The AKR1C3-Activated Prodrug OBI-3424 Exerts Profound In Vivo Efficacy Against Preclinical Models of T-Cell Acute Lymphoblastic Leukemia (T-ALL); a Pediatric Preclinical Testing Consortium Study , 2018 .
[17] David Haussler,et al. TumorMap: Exploring the Molecular Similarities of Cancer Samples in an Interactive Portal. , 2017, Cancer research.
[18] Kun Mu,et al. Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma , 2017, Cancer cell.
[19] J. Khan,et al. Identification of GPC2 as an Oncoprotein and Candidate Immunotherapeutic Target in High-Risk Neuroblastoma. , 2017, Cancer cell.
[20] L. Tang,et al. Loss of heterozygosity on chromosome 16q increases relapse risk in Wilms’ tumor: a meta-analysis , 2017, Oncotarget.
[21] Anang A. Shelat,et al. Orthotopic Patient-Derived Xenografts of Pediatric Solid Tumors , 2017, Nature.
[22] Roland Eils,et al. The whole-genome landscape of medulloblastoma subtypes , 2017, Nature.
[23] Daniel Baumhoer,et al. Recurrent mutation of IGF signalling genes and distinct patterns of genomic rearrangement in osteosarcoma , 2017, Nature Communications.
[24] Cheng Cheng,et al. THE GENOMIC LANDSCAPE OF PEDIATRIC AND YOUNG ADULT T-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA , 2017, Nature Genetics.
[25] Timothy L. Tickle,et al. STAR-Fusion: Fast and Accurate Fusion Transcript Detection from RNA-Seq , 2017, bioRxiv.
[26] Peter J. Park,et al. NGSCheckMate: software for validating sample identity in next-generation sequencing studies within and across data types , 2017, Nucleic acids research.
[27] Jiqiang Guo,et al. Stan: A Probabilistic Programming Language. , 2017, Journal of statistical software.
[28] P. Raman,et al. Enrichment of Targetable Mutations in the Relapsed Neuroblastoma Genome , 2016, PLoS genetics.
[29] Gregory P. Way,et al. A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma , 2017, BMC Genomics.
[30] Roland Eils,et al. Complex heatmaps reveal patterns and correlations in multidimensional genomic data , 2016, Bioinform..
[31] R. Lock,et al. A single nucleotide polymorphism genotyping platform for the authentication of patient derived xenografts , 2016, Oncotarget.
[32] Alexey Sergushichev,et al. An algorithm for fast preranked gene set enrichment analysis using cumulative statistic calculation , 2016 .
[33] Donna Neuberg,et al. The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice. , 2016, Cancer cell.
[34] B. Taylor,et al. deconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution , 2016, Genome Biology.
[35] P. Campbell,et al. Unscrambling the genomic chaos of osteosarcoma reveals extensive transcript fusion, recurrent rearrangements and frequent novel TP53 aberrations , 2015, Oncotarget.
[36] James Y. Zou. Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.
[37] et al.,et al. Jupyter Notebooks - a publishing format for reproducible computational workflows , 2016, ELPUB.
[38] R. Gibbs,et al. Genomic profiling of Sézary syndrome identifies alterations of key T cell signaling and differentiation genes , 2015, Nature Genetics.
[39] E. Birney,et al. Human genomics: The end of the start for population sequencing , 2015, Nature.
[40] Sven Rahmann,et al. Mutational dynamics between primary and relapse neuroblastomas , 2015, Nature Genetics.
[41] Gudrun Schleiermacher,et al. Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations , 2015, Nature Genetics.
[42] G. Abecasis,et al. An efficient and scalable analysis framework for variant extraction and refinement from population-scale DNA sequence data , 2015, Genome research.
[43] Jing Ma,et al. Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia , 2015, Nature Communications.
[44] W. Sung,et al. TP53 intron 1 hotspot rearrangements are specific to sporadic osteosarcoma and can cause Li-Fraumeni syndrome , 2015, Oncotarget.
[45] Edwin Cuppen,et al. Sambamba: fast processing of NGS alignment formats , 2015, Bioinform..
[46] Donna M. Muzny,et al. BCOR-CCNB3 Fusions Are Frequent in Undifferentiated Sarcomas of Male Children , 2014, Modern Pathology.
[47] Carson C Chow,et al. Second-generation PLINK: rising to the challenge of larger and richer datasets , 2014, GigaScience.
[48] Paul Theodor Pyl,et al. HTSeq—a Python framework to work with high-throughput sequencing data , 2014, bioRxiv.
[49] O. Kallioniemi,et al. FusionCatcher – a tool for finding somatic fusion genes in paired-end RNA-sequencing data , 2014, bioRxiv.
[50] Li Ding,et al. Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations. , 2014, Cancer discovery.
[51] F. Speleman,et al. Emergence of new ALK mutations at relapse of neuroblastoma. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[52] G. Getz,et al. Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors. , 2014, Cancer discovery.
[53] Simon White,et al. Launching genomics into the cloud: deployment of Mercury, a next generation sequence analysis pipeline , 2014, BMC Bioinformatics.
[54] R. Pieters,et al. Gain of 1q is a marker of poor prognosis in Wilms' tumors , 2013, Genes, chromosomes & cancer.
[55] Joshua M. Stuart,et al. The Cancer Genome Atlas Pan-Cancer analysis project , 2013, Nature Genetics.
[56] Emmanuel Barillot,et al. Breakpoint Features of Genomic Rearrangements in Neuroblastoma with Unbalanced Translocations and Chromothripsis , 2013, PloS one.
[57] David T. W. Jones,et al. Signatures of mutational processes in human cancer , 2013, Nature.
[58] Steven A. Roberts,et al. Mutational heterogeneity in cancer and the search for new cancer genes , 2014 .
[59] Ellen T. Gelfand,et al. The Genotype-Tissue Expression (GTEx) project , 2013, Nature Genetics.
[60] Steven J. M. Jones,et al. The genetic landscape of high-risk neuroblastoma , 2013, Nature Genetics.
[61] Thomas R. Gingeras,et al. STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..
[62] L. Mariani,et al. Loss of heterozygosity analysis at different chromosome regions in Wilms tumor confirms 1p allelic loss as a marker of worse prognosis: a study from the Italian Association of Pediatric Hematology and Oncology. , 2013, The Journal of urology.
[63] Jun Wang,et al. SOAPfuse: an algorithm for identifying fusion transcripts from paired-end RNA-Seq data , 2013, Genome Biology.
[64] Chris Williams,et al. RNA-SeQC: RNA-seq metrics for quality control and process optimization , 2012, Bioinform..
[65] D. Zwijnenburg,et al. Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes , 2012, Nature.
[66] Nazneen Rahman,et al. Stratification of Wilms tumor by genetic and epigenetic analysis , 2012, Oncotarget.
[67] David T. W. Jones,et al. Genome Sequencing of Pediatric Medulloblastoma Links Catastrophic DNA Rearrangements with TP53 Mutations , 2012, Cell.
[68] Kiran C. Bobba,et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia , 2012, Nature.
[69] Aleksandar Milosavljevic,et al. An integrative variant analysis suite for whole exome next-generation sequencing data , 2012, BMC Bioinformatics.
[70] M. Hollingshead,et al. Real-time PCR-based assay to quantify the relative amount of human and mouse tissue present in tumor xenografts , 2011, BMC biotechnology.
[71] Colin N. Dewey,et al. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome , 2011, BMC Bioinformatics.
[72] N. Friedman,et al. Trinity: reconstructing a full-length transcriptome without a genome from RNA-Seq data , 2011, Nature Biotechnology.
[73] Süleyman Cenk Sahinalp,et al. deFuse: An Algorithm for Gene Fusion Discovery in Tumor RNA-Seq Data , 2011, PLoS Comput. Biol..
[74] G. Getz,et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers , 2011, Genome Biology.
[75] R. Gibbs,et al. Targeted enrichment beyond the consensus coding DNA sequence exome reveals exons with higher variant densities , 2011, Genome Biology.
[76] M. DePristo,et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.
[77] P. Rao,et al. A clinically relevant orthotopic xenograft model of ependymoma that maintains the genomic signature of the primary tumor and preserves cancer stem cells in vivo. , 2010, Neuro-oncology.
[78] Cole Trapnell,et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. , 2010, Nature biotechnology.
[79] Hongkai Ji,et al. Analyzing 'omics data using hierarchical models , 2010, Nature Biotechnology.
[80] G. Weinstock,et al. A SNP discovery method to assess variant allele probability from next-generation resequencing data. , 2010, Genome research.
[81] Richard Durbin,et al. Fast and accurate long-read alignment with Burrows–Wheeler transform , 2010, Bioinform..
[82] Wes McKinney,et al. Data Structures for Statistical Computing in Python , 2010, SciPy.
[83] Kai Ye,et al. Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads , 2009, Bioinform..
[84] Gonçalo R. Abecasis,et al. The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..
[85] Richard Durbin,et al. Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .
[86] Jiang Qian,et al. TiGER: A database for tissue-specific gene expression and regulation , 2008, BMC Bioinformatics.
[87] Joseph Zeidner,et al. The pediatric preclinical testing program: Description of models and early testing results , 2007, Pediatric blood & cancer.
[88] Manuel A. R. Ferreira,et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.
[89] Peter Houghton,et al. Credentialing preclinical pediatric xenograft models using gene expression and tissue microarray analysis. , 2007, Cancer research.
[90] Andrew Gelman,et al. Multilevel (Hierarchical) Modeling: What It Can and Cannot Do , 2006, Technometrics.
[91] Kathleen F. Kerr,et al. The External RNA Controls Consortium: a progress report , 2005, Nature Methods.
[92] M. Pecht,et al. IC Component Socket Materials , 2005 .
[93] R. Lock,et al. Characterization of childhood acute lymphoblastic leukemia xenograft models for the preclinical evaluation of new therapies. , 2004, Blood.
[94] H. Fine,et al. Testing of new agents in childhood cancer preclinical models: meeting summary. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[95] R. Lock,et al. The nonobese diabetic/severe combined immunodeficient (NOD/SCID) mouse model of childhood acute lymphoblastic leukemia reveals intrinsic differences in biologic characteristics at diagnosis and relapse. , 2002, Blood.